Surgical & Interventional Devices

Nuvasive — engineered solutions for spine and interventional device planning.

Align access systems, fixation sets, biologics handling, IFU / UDI packets, surgeon education, and field coverage before value analysis or first-case scheduling for hospitals, ASCs, and orthopedic groups.

View Surgical Products

Care setting match

Start with the environment where the device will be used.

Our advisors translate surgeon preference cards, sterilization paths, inventory rules, and case coverage into a practical equipment plan.

Hospital OR

Procedure volume planning, rep coverage windows, instrument set rotation, and UDI capture for enterprise purchasing teams.

Ambulatory Surgery

Compact tray strategy, rapid turnover support, and documentation packets sized for lean ASC teams.

Orthopedic Groups

Surgeon preference alignment, training cadence, and case readiness tools for multi-site spine programs.

Sterile Processing

Reprocessing guidance with autoclave parameters, instrument tracking, and validated packaging references.

Value Analysis

Evidence summaries, service assumptions, UDI data, and lifecycle cost notes prepared for committee review.

Guided surgical readiness

Plain-English support for clinically complex device decisions.

Nuvasive content is built for the people who must make a safe, documented, and operationally realistic choice before the first case is scheduled.

UDI

Traceable device packets

Catalog number, GTIN, UDI-DI / UDI-PI, IFU revision, sterilization notes, and shelf-life references are packaged before procurement handoff and GUDID lookup.

Case support planning

Rep coverage, loaner set timing, emergency kit flow, MTTR escalation, and surgeon preference-card training are mapped against procedure schedules.

QMS

Regulatory language you can use

Claims stay precise: FDA cleared 510(k) pathways (not “approved” unless PMA), CE marked under MDR 2017/745, ISO 13485 QMS, and ISO 14971 risk-file references from the DHF / DMR package.

SPD

Reprocessing reality

Reusable vs single-use economics, SAL 10⁻⁶ sterile assurance where validated, autoclave / ETO / vapor H₂O₂ notes, and ISO 11607 packaging expectations are reviewed with SPD.

"The most useful part was not a brochure. It was the side-by-side discussion of procedure volume, set availability, and how our SPD team would actually process the trays."

Director of Surgical Services, community hospital, Midwest US

"Nuvasive helped us make the value analysis packet readable for clinical, supply chain, and biomedical stakeholders without overstating outcomes."

Orthopedic service line administrator, multi-site specialty group

FDA cleared510(k) device pathway references

CE markedMDR 2017/745 documentation support

ISO 13485QMS-first device file discipline

UDI readyTraceability for procurement review

Questions surgeons and administrators ask first

Useful answers before a formal evaluation.

How do we compare reusable and single-use economics?

We model case volume, tray turns, reprocessing labor, replacement rates, and contamination control assumptions so the comparison is practical for your facility.

Can you support our current sterile processing workflow?

Yes. The review includes validated cleaning steps, packaging notes, shelf-life expectations, and whether additional instrument tracking is needed.

What does the value analysis packet include?

Expect IFU links, UDI references, regulatory summaries, training plans, service contacts, and plain-language risk notes for committee review.

Do you make outcome guarantees?

No. We provide device information and planning support; clinical outcomes depend on patient factors, surgical judgment, and the broader care pathway.

Bring your procedure goals, site constraints, and timeline.

Nuvasive will help you turn them into a surgical device evaluation plan your clinical and procurement teams can actually use.

Compare Support Plans